CTOs on the Move

Floyd Medical Center

www.floydmed.org

 
Floyd Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Floyd Medical Center is based in Rome, GA. You can find more information on Floyd Medical Center at www.floydmed.org
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.floydmed.org
  • 304 Turner Mccall Blvd SW
    Rome, GA USA 30165
  • Phone: 706.509.5000

Executives

Name Title Contact Details

Similar Companies

Innovative Medical Device Solutions (IMDS)

IMDS (Innovative Medical Device Solutions) provides comprehensive product development and supply chain management solutions for medical device companies, with a focus on the orthopedic industry. IMDS is the integration of the following companies: Leis

Avidon Health

Launched in 2020 following MedPro Wellness acquisition of SelfHelpWorks, Avidon Health is a team of behavior change experts who are passionate about providing health strategies that empower people to make positive life changes. We focus on the individual rather than the condition using innovative engagement technology, impactful courses and content, and care team support to drive meaningful outcomes at scale. Our mission: to change lives by fixing the engagement problem in healthcare.

BroMenn Healthcare System

BroMenn Healthcare System is a Normal, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eclipse Salon

Eclipse Salon is a Cortez, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForSight VISION5

ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.